A. Linder
- Oncology top 5%
- Immunology top 5%
- Immunotherapy and Immune Responses 8
-
- Lung Cancer Diagnosis and Treatment 13
- Pleural and Pulmonary Diseases 13
- Lung Cancer Treatments and Mutations 7
- Tracheal and airway disorders 6
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
- Microbiology top 10%
-
- Trauma Management and Diagnosis 6
-
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Bernward PasslickGodehard FriedelVincent BrichardM. ZielińskiJohan VansteenkisteFrédéric LehmannJacek JassemH. Toomes
- Journals
- The Thoracic and Cardiovascular Surgeon (7 papers)Journal of Clinical Oncology (5 papers)Interactive Cardiovascular and Thoracic Surgery (2 papers)
- Partner nations
- GermanyBelgiumSwitzerland
In The Last Decade
A. Linder
54 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Oncology 639
- Immunology 465
- Pulmonary and Respiratory Medicine 525
- Pharmacology 133
- Microbiology 9
Countries citing papers authored by A. Linder
This map shows the geographic impact of A. Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Linder more than expected).
Fields of papers citing papers by A. Linder
This network shows the impact of papers produced by A. Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Linder. The network helps show where A. Linder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Linder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2019 | 9 | |
| 4 | 2011 | 5 | |
| 5 | 2010 | 3 | |
| 6 | 2010 | 4 | |
| 7 | GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) | 2008 | 2 |
| 8 | 2008 | 12 | |
| 9 | 2008 | 229 | |
| 10 | 2007 | 4 | |
| 11 | 2004 | 0 | |
| 12 | 2004 | 28 | |
| 13 | 2000 | 13 | |
| 14 | 2000 | 5 | |
| 15 | 2000 | 10 | |
| 16 | 1996 | 28 | |
| 17 | 1993 | 2 | |
| 18 | 1993 | 20 | |
| 19 | 1993 | 14 | |
| 20 | 1989 | 1 |
About A. Linder
A. Linder is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology, Oncology, Immunology and Anesthesiology and Pain Medicine, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (13 papers), Pleural and Pulmonary Diseases (13 papers), Immunotherapy and Immune Responses (8 papers), Lung Cancer Treatments and Mutations (7 papers), Trauma Management and Diagnosis (6 papers), Tracheal and airway disorders (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Oncology (639 citations), Immunology (465 citations), Pulmonary and Respiratory Medicine (525 citations), Pharmacology (133 citations) and Microbiology (9 citations). A. Linder has collaborated with scholars based in Germany, Belgium and Switzerland. Frequent co-authors include Bernward Passlick, Godehard Friedel, Vincent Brichard, M. Zieliński, Johan Vansteenkiste, Frédéric Lehmann, Jacek Jassem, H. Toomes, Emilio Esteban and Péter Fritz. Their work appears in journals such as The Thoracic and Cardiovascular Surgeon, Journal of Clinical Oncology, Interactive Cardiovascular and Thoracic Surgery, Lung Cancer and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.